Renal Medullary Carcinoma Response to Chemotherapy: a Referral Center Experience in Brazil

Renal medullary carcinoma (RMC) is rare, accounting for less than 1% of all renal neoplasms. Case reports suggest RMC is highly aggressive, poorly responsive to chemotherapy, often metastatic at diagnosis, affects young men with sickle cell trait, and median overall survival (mOS) is less than 12 mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Maroja Silvino, Marina Cavalcanti, Venchiarutti Moniz, Camila Motta, Munhoz Piotto, Gustavo Henrique, Siqueira, Sheila, Galapo Kann, Ariel, Dzik, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804819/
https://www.ncbi.nlm.nih.gov/pubmed/24179656
http://dx.doi.org/10.4081/rt.2013.e44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804819/
https://www.ncbi.nlm.nih.gov/pubmed/24179656
http://dx.doi.org/10.4081/rt.2013.e44

Ejemplares similares